086900 Stock Chart & Stats
$79000.00
$2,200.00(2.86%)
―
--
Day’s Range― - ―
52-Week Range$66,000.00 - $148,900.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₩473.67B
Enterprise Value$749.84K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)23.9
Beta0.38
Next Earnings
Aug 07, 2026EPS Estimate
729.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,298,497
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4,022.83
Revenue Forecast (FY)₩255.64B
086900 FAQ
What was Medy-Tox Inc.’s price range in the past 12 months?
Medy-Tox Inc. lowest stock price was $66000.00 and its highest was $148900.00 in the past 12 months.
What is Medy-Tox Inc.’s market cap?
Medy-Tox Inc.’s market cap is ₩473.67B.
When is Medy-Tox Inc.’s upcoming earnings report date?
Medy-Tox Inc.’s upcoming earnings report date is Aug 07, 2026 which is today.
How were Medy-Tox Inc.’s earnings last quarter?
Currently, no data Available
Is Medy-Tox Inc. overvalued?
According to Wall Street analysts Medy-Tox Inc.’s price is currently Undervalued.
Does Medy-Tox Inc. pay dividends?
Medy-Tox Inc. does not currently pay dividends.
What is Medy-Tox Inc.’s EPS estimate?
Medy-Tox Inc.’s EPS estimate is 729.09.
How many shares outstanding does Medy-Tox Inc. have?
Medy-Tox Inc. has 7,298,497 shares outstanding.
What happened to Medy-Tox Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medy-Tox Inc.?
Currently, no hedge funds are holding shares in KR:086900
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JW Pharmaceutical Corporation
―
Bukwang Pharmaceutical Co., Ltd.
―
Komipharm International Co., Ltd
―
AbClon, Inc.
―
Ildong Pharmaceutical Co., Ltd.
―